[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 17",
    "summary": "Read our weekly summary of companies that changed their dividends, companies with upcoming ex-dividend dates, and companies with upcoming pay dates. Access the full article here.",
    "url": "https://finnhub.io/api/news?id=9b2a01b624677892059b7a8132b4efbc29a18735cc952241fa7696e5a9f35bc9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755280129,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 17",
      "id": 136372867,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Read our weekly summary of companies that changed their dividends, companies with upcoming ex-dividend dates, and companies with upcoming pay dates. Access the full article here.",
      "url": "https://finnhub.io/api/news?id=9b2a01b624677892059b7a8132b4efbc29a18735cc952241fa7696e5a9f35bc9"
    }
  },
  {
    "ts": null,
    "headline": "Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet",
    "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
    "url": "https://finnhub.io/api/news?id=159c9d44a6ad50d35d9031eadf770ad7e68b0dd4a98f734faec773540024d088",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755266411,
      "headline": "Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet",
      "id": 136376392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
      "url": "https://finnhub.io/api/news?id=159c9d44a6ad50d35d9031eadf770ad7e68b0dd4a98f734faec773540024d088"
    }
  },
  {
    "ts": null,
    "headline": "SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease",
    "summary": "Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.",
    "url": "https://finnhub.io/api/news?id=5675b0deda13e89e44b64439774e282814490a1ce73ae624d22408d1ef056a85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755265800,
      "headline": "SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease",
      "id": 136370282,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.",
      "url": "https://finnhub.io/api/news?id=5675b0deda13e89e44b64439774e282814490a1ce73ae624d22408d1ef056a85"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Salesforce share gains contribute to Dow's 213-point climb",
    "summary": "UnitedHealth, Salesforce share gains contribute to Dow's 213-point climb",
    "url": "https://finnhub.io/api/news?id=789f6102b1ee49af7f4bba603f2f3318eec7def2fabac8cf271a24f8b118e015",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755251100,
      "headline": "UnitedHealth, Salesforce share gains contribute to Dow's 213-point climb",
      "id": 136385206,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Salesforce share gains contribute to Dow's 213-point climb",
      "url": "https://finnhub.io/api/news?id=789f6102b1ee49af7f4bba603f2f3318eec7def2fabac8cf271a24f8b118e015"
    }
  }
]